Bora Pharmaceuticals Co Ltd (6472) Stock Price & News

6472:TPE

Bora Pharmaceuticals Co Ltd

NT$399.50

+2.70%

(+10.50) 1D

Nov 6, 1:30:34 PM GMT+8 · TWD

All symbols

	Symbol	Price	Change	% Change

Next call in 5 days

Thu, Nov 12, 9:00 AM

Fiscal period

Q3 2026

- / NT$5.23

Revenue / Est. (TWD)

- / 6.28B

Fiscal Q3 2026 earnings call

Waiting for the earnings call

At a glance: upcoming earnings

Insights from the latest news and reports

Previous reportsAll values in TWD

Loading Previous Earnings...

All values in TWD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	4.81B	4.86B	4.00B	5.89B
Cost of goods sold	2.63B	3.09B	2.56B	3.46B
Cost of revenue	2.63B	3.09B	2.56B	3.46B
Research and development expenses	147.09M	181.25M	167.93M	190.74M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	961.21M	1.03B	866.09M	1.25B
Operating expense	1.11B	1.22B	1.04B	1.44B
Total operating expenses	3.74B	4.30B	3.59B	4.90B
Operating income	1.06B	556.34M	407.24M	986.64M
Other non operating income	36.54M	15.19M	24.01M	-15.28M
EBT including unusual items	895.42M	809.67M	221.15M	813.10M
EBT excluding unusual items	926.44M	375.02M	222.24M	788.94M
Income tax expense	73.70M	381.93M	174.25M	205.59M
Effective tax rate	8.23%	47.17%	78.79%	25.28%
Other operating expenses	396.00K	1.24M	1.37M	-
Net income	633.61M	331.76M	25.84M	555.76M
Net profit margin	13.18%	6.83%	0.65%	9.44%
Earnings per share	4.99	2.78	0.20	4.24
Interest and investment income	2.67M	10.49M	6.25M	11.16M
Interest expense	-125.12M	-122.01M	-113.73M	-124.33M
Net interest expenses	-122.44M	-111.52M	-107.48M	-113.17M
Depreciation and amortization charges	-	-	-	-
EBITDA	1.28B	784.95M	634.54M	1.27B
Gain or loss from assets sale	-10.15M	1.32M	63.00K	2.00K

Finance